Post Marketing Information PAC 31/12/2024 ELREXFIO (ELRANATAMAB) PATIENT CARD: IMPORTANT SAFETY INFORMATION FOR PATIENTS RECEIVING TREATMENT WITH ELREXFIO
SUBCUTANEOUS Select a brand starting with the letter: E ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML [SIN17155P] ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML [SIN17156P]